Phase II multicentric study of concurrent chemoradiation (CCR) with biweekly gemcitabine after induction chemotherapy with cisplatin and gemcitabine in unresectable stage III non small cell lung cancer (NSCLC)

Small Cell Lung ◽

Multicentric Study ◽

Phase II multicentric study of concurrent chemoradiation (CCR) with biweekly gemcitabine after induction chemotherapy with cisplatin and gemcitabine in unresectable stage III non small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7322 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7322-7322

Author(s):

R. Blanco ◽

J. Solé ◽

M. Nogué ◽

J. Montesinos ◽

E. Gallardo ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Multicentric Study ◽

Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation with twice-weekly gemcitabine in unresectable stage III non-small cell lung cancer: Final results of a phase II study

Lung Cancer ◽

10.1016/j.lungcan.2008.02.024 ◽

2008 ◽

Vol 62 (1) ◽

pp. 62-71 ◽

Cited By ~ 14

Author(s):

Remei Blanco ◽

Josep Solé ◽

Jesús Montesinos ◽

Carlos Mesía ◽

Manuel Algara ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

PD-039 Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation (CCR) with biweekly gemcitabine in unresectable stage III non small cell lung cancer (NSCLC): Final results of a phase II study

Lung Cancer ◽

10.1016/s0169-5002(05)80371-x ◽

2005 ◽

Vol 49 ◽

pp. S77

Author(s):

R. Blanco ◽

J. Solé ◽

M. Nogué ◽

J. Montesinos ◽

E. Gallardo ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Phase II study of induction chemotherapy with gemcitabine and carboplatin (IndGC) followed by paclitaxel and carboplatin with concurrent thoracic radiation (PCRT) for patients with unresectable stage III non-small-cell lung cancer (NSCLC): MCC-13240

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7307 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7307-7307

Author(s):

C. C. Williams ◽

H. Wagner ◽

H. Greenberg ◽

A. Sharma ◽

T. Hazelton ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Unresectable Stage ◽

Thoracic Radiation

Induction Chemotherapy Plus Concurrent Chemoradiation Therapy (ICCRT) Versus Concurrent Chemoradiation Therapy (CRT) in the Treatment of Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2012.07.1472 ◽

2012 ◽

Vol 84 (3) ◽

pp. S552

Author(s):

J. Chang ◽

S. Moon ◽

K. Cho ◽

T. Kim ◽

H. Kim ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Cell Lung Cancer ◽

Small Cell ◽

Chemoradiation Therapy ◽

Small Cell Lung ◽

Unresectable Stage ◽

Concurrent Chemoradiation Therapy

A phase II trial of induction chemotherapy followed by concomitant chemo-radiotherapy in stage IIIb non small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/0169-5002(94)94475-x ◽

1994 ◽

Vol 11 ◽

pp. 181

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Stage Iiib ◽

Small Cell Lung

HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer

Radiotherapy and Oncology ◽

10.1016/j.radonc.2018.10.032 ◽

2019 ◽

Vol 131 ◽

pp. 27-34 ◽

Cited By ~ 6

Author(s):

Yirui Zhai ◽

Honglian Ma ◽

Zhouguang Hui ◽

Lujun Zhao ◽

Dongming Li ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Continuous Infusion ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung ◽

Docetaxel plus cisplatin as neoadjuvant chemotherapy for unresectable stage III Non-Small-Cell Lung Cancer (NSCLC): A phase II study

Lung Cancer ◽

10.1016/s0169-5002(00)80374-8 ◽

2000 ◽

Vol 29 (1) ◽

pp. 113

Author(s):

M Dediu ◽

T Horvat ◽

A Tarlea ◽

A Nicodin ◽

M Movanu ◽

...

Keyword(s):

Lung Cancer ◽

Neoadjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung ◽

Phase II Study of Concurrent Chemotherapy with Etoposide and Cisplatin (EP) and Radiation Therapy for Unresectable Stage III Non-small Cell Lung Cancer

Tuberculosis and Respiratory Diseases ◽

10.4046/trd.1997.44.4.776 ◽

1997 ◽

Vol 44 (4) ◽

pp. 776 ◽

Cited By ~ 1

Author(s):

Nam Hyun Hur ◽

Choon Taek Lee ◽

Jae Hag Kim ◽

Seung Mo Nam ◽

Yeon Hee Park ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Concurrent Chemotherapy ◽

Small Cell ◽

Small Cell Lung ◽

2145 Phase II study of induction chemotherapy followed by radiotherapy combined with daily Cisplatin in stage III inoperable non-small cell lung cancer (NSCLC)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(97)80912-1 ◽

1997 ◽

Vol 39 (2) ◽

pp. 313

Author(s):

T. Scolaro ◽

A. Ardizzoni ◽

S. Giudici ◽

F. Grossi ◽

M. Cosso ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung